首页 > 主讲嘉宾 > 详情
顾娟红(临床研究与运营副总裁)
个人简介

Maggie Gu (Juanhong) joined Junshi TopAlliance Biosciences in January of 2018 as the Vice President-Clinical Research and Operations. She has over 20 years of experience in Medicine development, medical affairs and Clinical Research operations. Prior to joining Junshi Bioscience, Maggie served as Senior Director-Clinical Development in Clinical Operations at AstraZeneca China since 2012. Before AZ, she was Head of Clinical Operations and Therapeutic Area Medical Science Director at GlaxoSmithKline China R&D from 2005. She held various positions such as  Medical affairs manager, Clinical Research Project Manager and Clinical Research Associate in Fujisawa Pharmaceutical China, MSD China and Daiichi Pharmaceutical China since 1997.

 

Throughout her career, Maggie has taken leadershiop role in dozens of global and China clnical development projects and clinical trials, making significant contributions to the successful development of several new medicines for China such as oxitinib and the first domestic PD-1 antibody named Toripalimab injection. Maggie owned her Pediatric medicine degree from Shanghai Medical University (Fudan University).

 

顾娟红,于20181月加入君实生物,就任临床研究与运营副总裁。有超过20年新药开发、医学事务、临床研究运营经验。在加入君实生物之前,自2012年起,在阿斯利康中国担任高级临床发展总监。2005年至2012年,历任葛兰素史克中国研发公司临床运营负责人以及治疗领域医学总监。加入葛兰素史克前,在藤泽制药中国、默沙东中国、第一制药中国历任医学事务经理、临床研究项目经理及临床研究专员。

 

曾领导数十项全球和中国临床开发项目及临床研究,为多个新药如奥西替尼、国产首个PD-1抗体药物特瑞普利单抗等在中国的成功上市做出突出贡献。毕业于上海医科大学(复旦大学),获儿科医学硕士学位。


发表论文